TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

Míreanna comhchosúla

• A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
  de réir: Islam, Nahidul
  Foilsithe / Cruthaithe: (2023)
• Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
  de réir: Tamanna, Shams Tahsin
  Foilsithe / Cruthaithe: (2020)
• Safety and efficacy of dutasteride for male Androgenetic Alopecia
  de réir: Islam, S.M. Zahidul
  Foilsithe / Cruthaithe: (2024)
• Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
  de réir: Khandker, Tahia Anjum
  Foilsithe / Cruthaithe: (2024)
• Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
  de réir: Akter, Anika
  Foilsithe / Cruthaithe: (2022)